Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02393664Phase 3Unknown
A Phase 3 trial of propofol injection (veterinary), bupivacaine hydrochloride 0.75% injection in lung cancer, sponsored by National Taiwan University Hospital. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02393664.